Atlanta GA 软组织肉瘤临床试验
8项针对 软组织肉瘤的研究正在 Atlanta及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
招募中1/2 期
- Children's Healthcare of Atlanta - Egleston Hospital, Atlanta
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
招募中1 期
- Emory University - Winship Cancer Institute, Atlanta
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Atlanta VA Medical Center, Decatur · 距离 6 英里
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
招募中1/2 期
- Children's Healthcare of Atlanta, Atlanta
Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
招募中观察性研究
- Emory Winship Cancer Institute, Atlanta
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
招募中1/2 期
- Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
招募中1/2 期
- Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta
REtroperitoneal SArcoma Registry: an International Prospective Initiative
招募中观察性研究
- Winship Cancer Institute, Emory · 距离 5 英里
其他城市的 软组织肉瘤试验
- Houston, TX32 项研究
- New York City, NY20 项研究
- Boston, MA18 项研究
- St. Louis, MO14 项研究
- Columbus, OH13 项研究
- Los Angeles, CA13 项研究
- Washington, DC12 项研究
- Memphis, TN11 项研究
- Philadelphia, PA10 项研究
- Nashville, TN9 项研究
- Rochester, MN9 项研究
- Aurora, CO9 项研究
Atlanta的其他研究
- 癌症（所有类型）50 项研究
- 非小细胞肺癌46 项研究
- 乳腺癌41 项研究
- 多发性骨髓瘤41 项研究
- 前列腺癌32 项研究
- 结直肠癌29 项研究
- 肺癌29 项研究
- 卵巢癌28 项研究
- 急性髓系白血病28 项研究
- 肥胖症27 项研究
- 转移性癌症27 项研究
- 心力衰竭25 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年9月29日。每项研究自行设定入选标准，由研究团队决定谁能参与。